Latest filing published 25 Jan 2024 for SELLAS Life Sciences Group, Inc..
Filing timeline
BuySaleInsider track record
Robert Francomano: trading record in brief
Robert Francomano is a declared insider at 2 companies; the most frequent names are Stemline Therapeutics Inc and SELLAS Life Sciences Group, Inc. In total, 12 filings cover trades dated from 23 December 2019 to 22 January 2024.
Every open-market trade on record is a sale: 7 sales worth €66k. Outside the open market, there are 3 share grants.
Most recently, on 25 January 2024, the filings show a share grant in SELLAS Life Sciences Group, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Francomano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common StockSEC:0001104659-24-006396:0
- 1,082 shares@ US$1.08100.0% of flowClass A Common StockSEC:0001104659-23-124687:0
- 12,000 shares0Common StockSEC:0001104659-23-010637:0
- 200,891 sharesCommon StockSEC:0001104659-20-071832:0
- 272 shares@ US$11.514.4% of flowCommon StockSEC:0001104659-20-057631:0
- 1,266 shares@ US$5.008.5% of flowCommon StockSEC:0001104659-20-033490:0
- 5,064 shares@ US$6.7247.3% of flowCommon StockSEC:0001104659-20-022139:0
- 105,939 shares0Common StockSEC:0001104659-20-022139:1
- 249 shares@ US$10.583.6% of flowCommon StockSEC:0001104659-20-000976:0
- 1,412 shares@ US$10.9721.3% of flowCommon StockSEC:0001104659-20-000976:1
- 893 shares@ US$10.7513.2% of flowCommon StockSEC:0001104659-20-000976:2
- 116 shares@ US$10.481.7% of flowCommon StockSEC:0001104659-20-000976:3
12 of 12 declarations